About Cris De Luca
Cris De Luca is a director at Click Therapeutics.
Cris De Luca first appears on SEC filings in 2021.
Experience
This experience comes from Cris De Luca's profile and from SEC filings. For roles taken from filings, the years are when the filings name Cris De Luca in the role, so the role may have started earlier or lasted longer.
BR
BranchLab Current
Board Observer
2026 – Present
TL
Trial Library Current
Board Observer
2025 – Present
QU
QuantHealth Current
Board Observer
2025 – Present
EM
Empatica Current
Board Member
2022 – Present
NU
Nucleai Current
Board Member
2022 – Present
ME
Medisafe® Current
Board Member
2021 – Present
Click Therapeutics, Inc. Current
Director
2020 – Present · New York, NY
Prescription software treatments for people with unmet medical needs.
SA
Sanofi Current
Partner, Global Head of AI & Digital Investments at Sanofi Ventures
2020 – Present
F2
FIFA World Cup™ Boston 2026
Host City , Boston 2026
2025 – 2026
CH
Carbon Health
Board Member
2023 – 2025
OH
Omada Health
Board Observer
2021 – 2025
AE
Aetion
Board Observer
2020 – 2025
CS
Common Sensing
Board Observer
2020 – 2021
S3
Science 37
Investor
2020 – 2021
FU
FundRx
Venture Partner
2018 – 2020
JJ
Johnson & Johnson
Head, JLABS @ Boston
2013 – 2020
FE
Future Energy
Co-Founder
2012 – 2015
BR
BrightMap
Principal
2011 – 2014
US
Ultra Light Startups
Co-Founder
2009 – 2013
NO
Novartis
Director, Emerging Technologies
2007 – 2013
Key Colleagues at Startups
The people Cris De Luca works with at each company, as listed on that company's latest Form D.
Click Therapeutics, Inc. · Form D, Oct 1, 2026
DK
David Klein
Founder & CEO, director
Randall Stanicky
Chief Financial Officer
JB
Jeffrey Berkowitz
Director
AZ
Alex Zisson
Director
MF
Maria Forero
Director
MM
Muzammil Mansuri
Director
LC
Lezrene Cunningham
Director
DF
David Friedman
Director
AC
Anthony Costello
Director
BR
Bruce Robertson
Director
DL
Douglas Langa
Director